FOI 25-0299 LD – Baby Formula Products at WHA 2025

This FOI is documentation of Personnel representation of Australia at the February 2025 WHO Executive board meeting in Geneva. It also includes briefing material relating to the draft resolution on the digital marketing of breastmilk substitutes.

Downloads

FOI 25-0299 LD – Baby Formula Products at WHA 2025

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

FOI number:
FOI 25-0299 LD
FOI release date:
Publication type:
Report
Audience:
General public
Description:
  1. Personnel representation of Australia at the February 2025 WHO Executive board (EB) meeting in Geneva, and who else was in the Australian delegation
  2. Briefing material relating to the draft resolution on the digital marketing of breastmilk substitutes (EB156/30) which sat under EB agenda item 14
  3. Any material since 1 October 2024 on discussions with INC or formula companies related to regulation of digital marketing of infant formula, breastmilk substitutes or other commercial milk formula products. (Follow on formula or Toddler Milk/ Formula) or on Australia's position at the WHA EB 156 meeting.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.